Matt Van de Rijn
Contact Information
-
Clinical Offices
Department of Pathology 300 Pasteur Dr L235 MC 5324 Stanford, CA 94305 Tel Work (650) 723-5252 Fax (650) 725-6902Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
-
Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Pathology and Laboratory Medicine
- Anatomic/Clinical Pathology
Professional Education
| Fellowship: | Stanford Hospital & Clinics, CA USA (1994) |
| Residency: | SUMC - Graduate Medical Education, CA (1994) |
| Board Certification: | Anatomic Pathology, American Board of Pathology (1993) |
| Medical Education: | Universiteit Van Amsterdam, Netherlands (1986) |
Web Site Links
Scientific Focus
Research Interests
Our research focuses on gene microarray analysis of human soft tissue tumors (sarcomas). In addition we work with tissue microarrays to characterize large numbers of novel antisera raised against peptides derived from genes found to be of interest during gene array analysis. These genes are not only identified in sarcomas but, through collaborations with other laboratories, also in a large number of other human neoplasms, including breast, kidney, prostate, lung, and liver tumors.
Clinical Trials
Publications
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A. 2009; (33): 14016-21
- Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers. Virchows Arch. 2009
- The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res. 2009; (3): 778-87
- Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma. Am J Pathol. 2009; (6): 2347-56
- Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene. 2009

